Exact Mass: 684.1271178

Exact Mass Matches: 684.1271178

Found 27 metabolites which its exact mass value is equals to given mass value 684.1271178, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

prodelphinidin A-2 4-(2-hydroxyethyl)thio ether|Prodelphinidin A2 4-(2-hydroxyethyl)thio ether

prodelphinidin A-2 4-(2-hydroxyethyl)thio ether|Prodelphinidin A2 4-(2-hydroxyethyl)thio ether

C32H28O15S (684.1148858)


   

(1S)-6-O-acetyl-1,5-anhydro-1-[5,7-dihydroxy-2-(4-hydroxyphenyl)-6-methoxy-4-oxo-4H-1-benzopyran-8-yl]-2-O-[(4-hydroxy-3,5-dimethoxyphenyl)carbonyl]-D-glucitol|hispidulin 8-C-(6-O-acetyl-2-O-syringoyl-beta-D-glucopyranoside)

(1S)-6-O-acetyl-1,5-anhydro-1-[5,7-dihydroxy-2-(4-hydroxyphenyl)-6-methoxy-4-oxo-4H-1-benzopyran-8-yl]-2-O-[(4-hydroxy-3,5-dimethoxyphenyl)carbonyl]-D-glucitol|hispidulin 8-C-(6-O-acetyl-2-O-syringoyl-beta-D-glucopyranoside)

C33H32O16 (684.1690272)


   
   
   
   
   

7-O-beta-D-Glucuronoside,3-O-(4-hydroxy-3,5-dimethoxycinnamoyl)-4,5,6,7-Tetrahydroxyflavone

7-O-beta-D-Glucuronoside,3-O-(4-hydroxy-3,5-dimethoxycinnamoyl)-4,5,6,7-Tetrahydroxyflavone

C32H28O17 (684.1326438000001)


   

COSMOSIIN HEXAACETATE

COSMOSIIN HEXAACETATE

C33H32O16 (684.1690272)


   
   
   
   

cis-[4,5-Bis-(4-bromophenyl)-2-(2-ethoxy-4-methoxyphenyl)-4,5-dihydroimidazol-1-YL]-[4-(2-hydroxyethyl)piperazin-1-YL]methanone

cis-[4,5-Bis-(4-bromophenyl)-2-(2-ethoxy-4-methoxyphenyl)-4,5-dihydroimidazol-1-YL]-[4-(2-hydroxyethyl)piperazin-1-YL]methanone

C31H34Br2N4O4 (684.0946643999999)


   
   

Ferroheme c

Ferroheme c

C34H36FeN4O4S2 (684.1527246)


A ferroheme coordination complex bearing 1-sulfanylethyl substituents at the 8- and 13-positions.

   

Eplivanserin (hemifumarate)

Eplivanserin (hemifumarate)

C19H21FN2O2.1/2C4H4O4 (684.1696562)


Eplivanserin (SR-46349) hemifumarate is a potent, selective and orally active 5-HT2A receptor antagonist, with an IC50 of 5.8 nM in rat cortical membrane, and a Kd of 1.14 nM. Eplivanserin hemifumarate displays >20-fold selectivity more selective for 5-HT2A than 5-HT2B and 5-HT2C[1][2].

   

(3s)-4-{[(2r,4r,5r,6s)-4,5-dihydroxy-2-(hydroxymethyl)-6-(3,4,5-trihydroxybenzoyloxy)oxan-3-yl]oxy}-4-oxo-3-[(3s,4s)-5,6,7-trihydroxy-3-(methoxycarbonyl)-1-oxo-3,4-dihydro-2-benzopyran-4-yl]butanoic acid

(3s)-4-{[(2r,4r,5r,6s)-4,5-dihydroxy-2-(hydroxymethyl)-6-(3,4,5-trihydroxybenzoyloxy)oxan-3-yl]oxy}-4-oxo-3-[(3s,4s)-5,6,7-trihydroxy-3-(methoxycarbonyl)-1-oxo-3,4-dihydro-2-benzopyran-4-yl]butanoic acid

C28H28O20 (684.1173888000001)


   

2-[(2s,4z)-4-[(2e,4e,6e,8e,10z,12e,14z)-11,15-dichloro-15-[(3s,5r)-3-chloro-5-methyloxolan-2-yl]-1-hydroxypentadeca-2,4,6,8,10,12,14-heptaen-1-ylidene]-3,5-dioxo-1-[(2r,4r,5r)-3,4,5-trihydroxyoxan-2-yl]pyrrolidin-2-yl]ethanimidic acid

2-[(2s,4z)-4-[(2e,4e,6e,8e,10z,12e,14z)-11,15-dichloro-15-[(3s,5r)-3-chloro-5-methyloxolan-2-yl]-1-hydroxypentadeca-2,4,6,8,10,12,14-heptaen-1-ylidene]-3,5-dioxo-1-[(2r,4r,5r)-3,4,5-trihydroxyoxan-2-yl]pyrrolidin-2-yl]ethanimidic acid

C31H35Cl3N2O9 (684.1408030000001)


   

(15r)-24-ethyl-5,7,11,13,17,19,23,25-octahydroxy-15-(4-hydroxyphenyl)-6-isopropyloctacyclo[14.11.1.1²,¹⁰.0³,⁸.0⁴,²⁶.0²⁰,²⁸.0²²,²⁷.0¹⁴,²⁹]nonacosa-1,3,5,7,10(29),11,13,16,18,20(28),22(27),23,25-tridecaene-9,21-dione

(15r)-24-ethyl-5,7,11,13,17,19,23,25-octahydroxy-15-(4-hydroxyphenyl)-6-isopropyloctacyclo[14.11.1.1²,¹⁰.0³,⁸.0⁴,²⁶.0²⁰,²⁸.0²²,²⁷.0¹⁴,²⁹]nonacosa-1,3,5,7,10(29),11,13,16,18,20(28),22(27),23,25-tridecaene-9,21-dione

C40H28O11 (684.1631538)


   

(5r,8s)-1,1',3,4',5,6',8'-heptahydroxy-8-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-5,6,7,8-tetrahydro-[2,2'-bixanthene]-9,9'-dione

(5r,8s)-1,1',3,4',5,6',8'-heptahydroxy-8-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-5,6,7,8-tetrahydro-[2,2'-bixanthene]-9,9'-dione

C32H28O17 (684.1326438000001)


   

(1r,2s,3r,4s,5r,7r,8s,9r,10r,11r,12r,15r)-9,15-bis(acetyloxy)-7-bromo-10-hydroxy-14-(iodomethyl)-4,8,12,14-tetramethyl-13-oxatetracyclo[10.2.2.0²,¹¹.0³,⁸]hexadecan-5-yl acetate

(1r,2s,3r,4s,5r,7r,8s,9r,10r,11r,12r,15r)-9,15-bis(acetyloxy)-7-bromo-10-hydroxy-14-(iodomethyl)-4,8,12,14-tetramethyl-13-oxatetracyclo[10.2.2.0²,¹¹.0³,⁸]hexadecan-5-yl acetate

C26H38BrIO8 (684.0794678000001)


   

2-{4-[11,15-dichloro-15-(3-chloro-5-methyloxolan-2-yl)-1-hydroxypentadeca-2,4,6,8,10,12,14-heptaen-1-ylidene]-3,5-dioxo-1-(3,4,5-trihydroxyoxan-2-yl)pyrrolidin-2-yl}ethanimidic acid

2-{4-[11,15-dichloro-15-(3-chloro-5-methyloxolan-2-yl)-1-hydroxypentadeca-2,4,6,8,10,12,14-heptaen-1-ylidene]-3,5-dioxo-1-(3,4,5-trihydroxyoxan-2-yl)pyrrolidin-2-yl}ethanimidic acid

C31H35Cl3N2O9 (684.1408030000001)


   

2-[(2s,4z)-4-[(2e,4e,6e,8e,10z,12e,14z)-11,15-dichloro-15-[(2s,3s,5r)-3-chloro-5-methyloxolan-2-yl]-1-hydroxypentadeca-2,4,6,8,10,12,14-heptaen-1-ylidene]-3,5-dioxo-1-[(2r,3r,4s,5r)-3,4,5-trihydroxyoxan-2-yl]pyrrolidin-2-yl]ethanimidic acid

2-[(2s,4z)-4-[(2e,4e,6e,8e,10z,12e,14z)-11,15-dichloro-15-[(2s,3s,5r)-3-chloro-5-methyloxolan-2-yl]-1-hydroxypentadeca-2,4,6,8,10,12,14-heptaen-1-ylidene]-3,5-dioxo-1-[(2r,3r,4s,5r)-3,4,5-trihydroxyoxan-2-yl]pyrrolidin-2-yl]ethanimidic acid

C31H35Cl3N2O9 (684.1408030000001)


   

6,16,27-triacetyl-5,15,28-trihydroxy-7,17,26-trimethylheptacyclo[20.8.0.0²,¹¹.0⁴,⁹.0¹²,²¹.0¹⁴,¹⁹.0²⁴,²⁹]triaconta-1,4,6,8,11,14,16,18,21,24,26,28-dodecaene-3,10,13,20,23,30-hexone

6,16,27-triacetyl-5,15,28-trihydroxy-7,17,26-trimethylheptacyclo[20.8.0.0²,¹¹.0⁴,⁹.0¹²,²¹.0¹⁴,¹⁹.0²⁴,²⁹]triaconta-1,4,6,8,11,14,16,18,21,24,26,28-dodecaene-3,10,13,20,23,30-hexone

C39H24O12 (684.1267703999999)


   

24-ethyl-5,7,11,13,17,19,23,25-octahydroxy-15-(4-hydroxyphenyl)-6-isopropyloctacyclo[14.11.1.1²,¹⁰.0³,⁸.0⁴,²⁶.0²⁰,²⁸.0²²,²⁷.0¹⁴,²⁹]nonacosa-1,3,5,7,10(29),11,13,16,18,20(28),22(27),23,25-tridecaene-9,21-dione

24-ethyl-5,7,11,13,17,19,23,25-octahydroxy-15-(4-hydroxyphenyl)-6-isopropyloctacyclo[14.11.1.1²,¹⁰.0³,⁸.0⁴,²⁶.0²⁰,²⁸.0²²,²⁷.0¹⁴,²⁹]nonacosa-1,3,5,7,10(29),11,13,16,18,20(28),22(27),23,25-tridecaene-9,21-dione

C40H28O11 (684.1631538)